Figures

Table 1.1 What is biotechnology?
Figure 1.1 The four pillars of biotechnology
Figure 2.1 Knowledge and skills enabling biotechnology
Figure 3.1 Simplified model of information flow in molecular biology
Figure 3.2 General scheme of gene expression
Figure 3.3 DNA: Chromosomes and genes
Figure 3.4 Protein translation
Table 3.1 Protein and enzyme functions
Table 3.2 Selected RNA types
Figure 4.1 Small-molecule and biologic drugs
Figure 4.2 Biotechnology drug categories
Figure 4.3 Basic and applied research
Figure 4.4 The process of drug development
Figure 4.5 Biotechnology drug development time
Figure 4.6 Declining time and cost of human genome sequencing
Table 4.1 Qualities of a "good" drug
Table 5.1 Selected nanotechnology applications in drug delivery
Table 6.1 Biotechnology application categories
Figure 6.1 Progress in agricultural yields
Figure 6.2 How cellulosic ethanol is made
Table 6.2 Selected industrial enzymes
Figure 6.3 U.S. babies born in states mandating genetic disorder testing
Figure 6.4 Stem cell types
Table 7.1 Intellectual property rights
Table 7.2 Top biotechnology patent holders
Table 8.1 Biotechnology regulating bodies
Figure 8.1 Clinical trial phases
Figure 8.2 Impact of the Orphan Drug Act
Figure 8.3 Impact of generic entry on drug price
Table 8.3 Drug names
Table 8.4 Selected generic drug naming conventions
Table 9.1 Biotechnology application categories
Figure 9.1 Biotechnology company activities
Table 9.2 Assessing biotechnology company maturity
Figure 10.1 Funding stages and sources
Table 10.1 Funding stages and investment sizes
Figure 11.1 R&D Stages
Figure 11.2 Estimated cost and duration of biotechnology drug development
Figure 12.1 Regulations affect sales: U.S. corn exports following partial EU ban
Figure 12.2 Measuring target market size
Figure 12.3 Simplified drug market model
Figure 12.4 Biotechnology product lifecycle
Figure 13.1 Pharmaceutical industry cost analysis
Figure 13.2 Producing and selling biotechnology products and services

A product of Logos Press